Cirugía y Radiología y Medicina Física
Departamento
ANA ISABEL
ALONSO VARONA
PROFESORADO CATEDRATICO/A DE UNIVERSIDAD
Publicaciones en las que colabora con ANA ISABEL ALONSO VARONA (21)
2023
-
Prophylactic Treatment of Intestinal Ischemia-Reperfusion Injury Reduces Mucosal Damage and Improves Intestinal Absorption
Journal of Inflammation Research, Vol. 16, pp. 4141-4152
2022
-
Conditioned Medium from H2O2-Preconditioned Human Adipose-Derived Stem Cells Ameliorates UVB-Induced Damage to Human Dermal Fibroblasts
Antioxidants, Vol. 11, Núm. 10
-
The Prevention of Ischemia-Reperfusion Injury in Elderly Rats after Lower Limb Tourniquet Use
Antioxidants, Vol. 11, Núm. 10
2021
-
Antioxidant-based therapy reduces early-stage intestinal ischemia-reperfusion injury in rats
Antioxidants, Vol. 10, Núm. 6
-
Effects of folinic acid administration on lower limb ischemia/reperfusion injury in rats
Antioxidants, Vol. 10, Núm. 12
2014
-
All-trans-retinoic acid counteract the tumor-stimulating effect of hepatectomy and increases survival of rats bearing liver metastases
Journal of Surgical Research, Vol. 188, Núm. 1, pp. 143-151
2010
-
Glutathione modulators reverse the pro-tumour effect of growth factors enhancing WiDr cell response to chemotherapeutic agents
Anticancer Research, Vol. 30, Núm. 4, pp. 1223-1231
2009
-
Glutathione modulation reverses the growth-promoting effect of growth factors, improving the 5-fluorouracil antitumour response in WiDr colon cancer cells
Anticancer Research, Vol. 29, Núm. 10, pp. 3957-3965
2006
-
Cytomodulation of interleukin-2 effect by L-2-oxothiazolidine-4-carboxylate on human malignant melanoma
Cancer Immunology, Immunotherapy, Vol. 55, Núm. 8, pp. 948-957
-
Influence of the level of γ-glutamyltranspeptidase activity on the response of poorly and moderately differentiated rhabdomyosarcoma cell lines to all-trans-retinoic acid
Anti-Cancer Drugs, Vol. 17, Núm. 10, pp. 1127-1139
2002
-
L-2-oxothiazolidine-4-carboxylate reverses the tumour growth-promoting effect of interleukin-2 and improves the anti-tumour efficacy of biochemotherapy in mice bearing B16 melanoma liver metastases
Melanoma Research, Vol. 12, Núm. 1, pp. 17-26
-
Role of γ-glutamyltranspeptidase on the response of poorly and moderately differentiated rhabdomyosarcoma cell lines to buthionine sulfoximine-induced inhibition of glutathione synthesis
Anti-Cancer Drugs, Vol. 13, Núm. 3, pp. 281-291
2000
-
Effects of L-2-oxothiazolidine-4-carboxylate on the cytotoxic activity and toxicity of cyclophosphamide in mice bearing B16F10 melanoma liver metastases
Melanoma Research, Vol. 10, Núm. 2, pp. 103-112
-
Tunicamycin treatment reduces intracellular glutathione levels: Effect on the metastatic potential of the rhabdomyosarcoma cell line S4MH
Chemotherapy, Vol. 46, Núm. 6, pp. 408-428
1999
1997
-
Interleukin-2 increases intracellular glutathione levels and reverses the growth inhibiting effects of cyclophosphamide on B16 melanoma cells
Clinical and Experimental Metastasis, Vol. 15, Núm. 3, pp. 329-337
1996
-
HOX genes and cell adhesion molecules in cancers.
The International journal of developmental biology, Vol. Suppl 1
-
Tumor-host interaction in non-random metastatic pattern distribution
Bulletin du Cancer, Vol. 83, Núm. 1, pp. 27-38
1995
-
The addition of interleukin-2 to cyclophosphamide therapy can facilitate tumor growth of B16 melanoma
Cancer Immunology Immunotherapy, Vol. 40, Núm. 5, pp. 292-298